Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Cidara Therapeutics is a biotechnology company focused on developing innovative drug-Fc conjugate immunotherapies targeting serious diseases. Its core platform, Cloudbreak, creates long-acting, potent therapies for viral infections like influenza and solid tumors, leveraging dual mechanisms of disease prevention and immune engagement. The company’s key products include CD388 for influenza prophylaxis and CBO421 for cancer, aiming to improve treatment efficacy and resistance profiles through proprietary, targeted biologics.
This description was generated via AI from an annual report. Updated about 1 year ago.